首頁 › 大腸直腸癌 › 密蘇里 › Kansas City
Kansas City, MO 的 大腸直腸癌 臨床試驗
16 項針對 大腸直腸癌 的研究正在 Kansas City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中歡迎健康志工
- Saint Luke's Hospital of Kansas City, Kansas City
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
招募中3 期
- Saint Lukes Hospital of Kansas City /ID# 279513, Kansas City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Kansas City Veterans Affairs Medical Center, Kansas City
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
招募中1 期
- St. Lukes Hospital of Kansas City, Kansas City
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
招募中1 期
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距離 5 英里
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
招募中2 期
- Saint Lukes Hospital of Kansas City /ID# 270633, Kansas City
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
招募中1 期
- Research Site, Westwood · 距離 5 英里
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
招募中2/3 期
- Local Institution - 0318, Kansas City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
招募中1/2 期
- The University of Kansas Clinical Research Center, Westwood · 距離 5 英里
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- Saint Luke'S Hospital of Kansas City, Kansas City
- Midamerica Cancer Care, Kansas City
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
招募中1 期
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距離 5 英里
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
招募中3 期
- Clinical Study Site, Westwood · 距離 5 英里
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
招募中1/2 期
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距離 5 英里
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
招募中1 期
- MidAmerica Cancer Care, Kansas City
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
招募中4 期
- Midwest Oncology Associates - Kansas City, Kansas City
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- 還有 1 項
其他城市的 大腸直腸癌 試驗
- Houston, TX102 項研究
- New York City, NY78 項研究
- Nashville, TN69 項研究
- Boston, MA63 項研究
- Los Angeles, CA59 項研究
- Arlington, VA52 項研究
- St. Louis, MO50 項研究
- San Antonio, TX46 項研究
- Philadelphia, PA44 項研究
- Grand Rapids, MI40 項研究
- Baldwin Park, CA37 項研究
- Chicago, IL34 項研究
Kansas City 的其他研究
- 乳癌34 項研究
- 非小細胞肺癌31 項研究
- 心臟衰竭25 項研究
- 癌症（所有類型）21 項研究
- 肺癌19 項研究
- 轉移性癌症15 項研究
- 急性髓系白血病15 項研究
- 前列腺癌14 項研究
- 卵巢癌11 項研究
- 肥胖症11 項研究
- 第二型糖尿病11 項研究
- 心血管疾病11 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。